Comparison

Recombinant Mouse VCAM1 Protein (His Tag)(Active)

Item no. ELS-PKSM040831-200ug
Manufacturer Elabscience
Amount 200ug
Category
Type Proteins
Specific against Mouse
Host HEK293 cells
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias CD106,Vascular cell adhesion protein 1, Vcam1, L1CAM,VCMA1,Vcam-1
Similar products L1CAM, Vascular cell adhesion protein 1, Vcam1, CD106, Vcam-1, VCMA1
Available
Synonym
CD106, Vascular cell adhesion protein 1, Vcam1, L1CAM, VCMA1, Vcam-1
Storage
according to manual
Activity
Measured by the ability of the immobilized protein to support adhesion of U937 human histiocytic lymphoma cells. When 5 x 10E4 cells/well are added to mouse VCAM1 coated plates (10 ug/ml with 100 ul/well), approximately 70%-80% cells will adhere after 1 hour at RT.
Protein Construction
A DNA sequence encoding the extracellular domain (Met 1-Glu 698) of mouse VCAM1 (NP_035823.3) was fused with the a polyhistidine tag at the C-terminus.
Sequence
Met 1-Glu 698
Fusion tag
C-His
Accession
NP_035823.3
Shipping
This product is provided as lyophilized powder which is shipped with ice packs.
Purity
> 97 % as determined by SDS-PAGE
Endotoxin
< 1.0 EU per ug of the protein as determined by the LAL method.
Stability and Storage
Lyophilized proteins are stable for up to 12 months when stored at -20 to -80CC. Reconstituted protein solution can be stored at 4-8C for 2-7 days. Aliquots of reconstituted samples are stable at < -20C for 3 months.
Mol Mass
75.8 kDa
AP Mol Mass
90-100 kDa
Formulation
Lyophilized from sterile PBS, pH 7.4
Reconstitution
Please refer to the printed manual for detailed information.
Background
Vascular cell adhesion molecule 1 (VCAM-1), also known as CD106, is a cell surface sialoglycoprotein belonging to the immunoglobulin superfamily. Two forms of VCAM-1 with either six or seven extracellular Ig-like domains are generated by alternative splicing, with the longer form predominant. VCAM-1 is an endothelial ligand for very late antigen-4 (VLA-4) and α 4ß 7 integrin expressed on leukocytes, and thus mediates leukocyte-endothelial cell adhesion and signal transduction. VCAM-1 expression is induced on endothelial cells during inflammatory bowel disease, atherosclerosis, allograft rejection, infection, and asthmatic responses. During these responses, VCAM-1 forms a scaffold for leukocyte migration. VCAM-1 also activates signals within endothelial cells resulting in the opening of an " endothelial cell gate" through which leukocytes migrate. VCAM-1 has been identified as a potential anti-inflammatory therapeutic target, the hypothesis being that reduced expression of VCAM-1 will slow the development of atherosclerosis. In addition, VCAM-1-activated signals in endothelial cells are regulated by cytokines indicating that it is important to consider both endothelial cell adhesion molecule expression and function during inflammatory processes.Immune Checkpoint      Immunotherapy      Cancer Immunotherapy      Targeted Therapy

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close